FAQ

tiotropium 0.018 MG Inhalant Powder

Known as: TIOTROPIUM 18MCG INHL CAP 30, TIOTROPIUM 18MCG CAP,INHL,30, TIOTROPIUM 18MCG INHL CAP 90 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2008-2017
01220082017

Related topics

Related topics

7 relations
AsthmaBronchodilation [PE]Cholinergic Antagonists [MoA]Inhalant Powder
(More)

Broader (1)

BRONCHODILATORS,ANTICHOLINERGIC

Narrower (1)

tiotropium 0.018 MG Inhalant Powder [Spiriva]

Related mentions per year

Related mentions per year

1936-2018
19401960198020002020
tiotropium 0.018 MG Inhalant Powder
Asthma
Bronchodilation [PE]
tiotropium
Inhalant Powder
BRONCHODILATORS,ANTICHOLINERGIC

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Neue Trends für Hörimplantate
  • Red
  • HNO Nachrichten
  • 2016
— Die neuen GINA-Leitlinien von 2015 verändern die Therapie des schweren Asthmas: Orale Steroide wurden zurückgestuft, besser… (More)
Is this relevant?
2016
2016
Schweres Asthma: orale Steroide zurückgestuft, Biologika aufgewertet
— Die neuen GINA-Leitlinien von 2015 verändern die Therapie des schweren Asthmas: Orale Steroide wurden zurückgestuft, besser… (More)
Is this relevant?
Review
2016
Review
2016
A systematic review of comparative studies of tiotropium Respimat® and tiotropium HandiHaler® in patients with chronic obstructive pulmonary disease: does inhaler choice matter?
BACKGROUND In many countries worldwide, the long-acting anticholinergic drug tiotropium is available as a dry powder formulation… (More)
  • figure 1
  • table 1
  • table 1
  • table 1
  • figure 2
Is this relevant?
2016
2016
The Effect of Tiotropium in Symptomatic Asthma Despite Low- to Medium-Dose Inhaled Corticosteroids: A Randomized Controlled Trial.
BACKGROUND Tiotropium, a once-daily long-acting anticholinergic bronchodilator, has demonstrated efficacy in patients with asthma… (More)
  • figure 1
  • table I
  • table II
  • figure 2
  • figure 3
Is this relevant?
2016
2016
Tiotropium Respimat® Versus HandiHaler®: Comparison of Bronchodilator Efficacy of Various Doses in Clinical Trials
INTRODUCTION The long-acting muscarinic antagonist tiotropium bromide is approved in many countries as maintenance therapy for… (More)
  • figure 1
  • figure 2
Is this relevant?
2016
2016
Pflanzlich gegen Magenbeschwerden
Eine auf dem Kongress der American oracic Society vorgestellte Post-hoc-Analyse der Studie WISDOM (Withdrawel of Inhaled Steroids… (More)
Is this relevant?
2016
2016
Neue Praxisleitfäden zu Erkältungskrankheiten
Eine auf dem Kongress der American oracic Society vorgestellte Post-hoc-Analyse der Studie WISDOM (Withdrawel of Inhaled Steroids… (More)
Is this relevant?
2014
2014
Pooled analysis of tiotropium Respimat(®) pharmacokinetics in cystic fibrosis.
Tiotropium is the first bronchodilator to be studied systematically in cystic fibrosis (CF). We investigated whether any… (More)
Is this relevant?
Highly Cited
2013
Highly Cited
2013
Tiotropium Respimat inhaler and the risk of death in COPD.
BACKGROUND Tiotropium delivered at a dose of 5 μg with the Respimat inhaler showed efficacy similar to that of 18 μg of… (More)
Is this relevant?
2008
2008
Tiotropium in der Langzeittherapie bei COPD
Tiotropium ist als inhalatives Anticholinergikum mit einer 24-stündigen Wirksamkeit in der Therapie der COPD (chronisch… (More)
Is this relevant?